1. Introduction {#sec1-nutrients-08-00488}
===============

Recently, studies have implied that nutrition during fetal and neonatal life can have profound effects on lifespan, glucose, and lipid metabolism. Human studies conducted in 1944--1945 revealed that undernutrition during early pregnancy was associated with glucose intolerance and increased serum insulin concentrations later in life (50--58 years-old) \[[@B1-nutrients-08-00488]\]. It was the first time that scientists addressed the impact of adverse environmental factors in early life on the occurrence of metabolic diseases in adulthood \[[@B2-nutrients-08-00488]\]. Later work confirmed and extended this hypothesis by showing significant opposite correlations between birth weight and the risk of adult obesity \[[@B3-nutrients-08-00488],[@B4-nutrients-08-00488]\]. One important mechanism believed to be involved in this relationship is DNA methylation. DNA methylation changes normally occur within CpG-rich regions (CpG islands). CpG islands are usually located near the promoter regions of genes. Methylation within the promoter region can negatively affect gene expression \[[@B5-nutrients-08-00488]\]. DNA methylation is a key regulator of normal metabolic balance and the occurrence of disease \[[@B6-nutrients-08-00488],[@B7-nutrients-08-00488]\]. DNA methylation changes are particularly sensitive in "early life window period". DNA methylation changes occurring in utero may be passed on to offspring and may subsequently lead to metabolic diseases \[[@B8-nutrients-08-00488]\].

An increasing number of studies show that chromium (Cr (III)) supplementation is beneficial in maintaining healthy lipid metabolism, regulating appetite, reducing fat mass, and increasing lean body mass \[[@B9-nutrients-08-00488]\]. The minimum suggested daily chromium intake is 30 μg. However, the average dietary chromium intake for adults is far below this recommendation in many countries \[[@B10-nutrients-08-00488],[@B11-nutrients-08-00488]\]. In particular, pregnant women and elderly individuals are more prone to the chromium deficiency \[[@B12-nutrients-08-00488]\], due to increased metabolic stress and decreased absorption ratio \[[@B13-nutrients-08-00488],[@B14-nutrients-08-00488]\]. Vincent et al. report that a chromium-insufficient diet leads to an increase in serum cholesterol, which can be ameliorated by chromium supplementation \[[@B15-nutrients-08-00488]\]. A recent study shows that chronic maternal chromium deficiency increases body fat and changes the lipid metabolism in rat pups. The mechanism involved is probably augmented by oxidative stress \[[@B16-nutrients-08-00488]\].

We hypothesized that exposure to maternal chromium restriction would have a sustained impact on the methylation of genes involved in lipid metabolism, thus lead to dyslipidemia in mice offspring. To identify this epigenetic alteration, we used a genome-wide DNA methylation approach in adipose tissue and tested whether epigenetic changes were associated with differential gene expression.

2. Materials and Methods {#sec2-nutrients-08-00488}
========================

2.1. Animals Protocol {#sec2dot1-nutrients-08-00488}
---------------------

This study was performed in strict accordance with the recommendations given by the Guide for the Care and Use of Laboratory Animals from the National Institute of Health. The protocol was approved by the Committee on the Ethics of Animal Experiments of Peking Union Medical Hospital (Permit Number: MC-07-6004). All efforts were made to minimize suffering. Seven-week-old C57BL/6J mice (18.5 ± 1.6 g) were acquired from the Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Peking Union Medical College (Beijing, China, SCXK-2014-0108). After 1 week of adaptation, virgin female C57BL mice were caged with males (2 females to 1 male) overnight. Copulation was confirmed the next morning by establishing the formation of a vaginal plug. Midnight was considered as day 0 of gestation. Pregnant mothers (*n* = 16) were fed either the control diet (C, *n* = 8) or low chromium diet (L, *n* = 8). The control diet was a casein-based diet formulated on the basis of the American Institute of Nutrition AIN-93G diet and contained 1.19 mg/kg chromium. The low chromium diet (reduced only in chromium) contained 0.14 mg/kg chromium (88.23% of chromium restriction compared to control diet). The concentration of dietary chromium was analyzed using an atomic absorption spectrometer (TAS986, Beijing Persee General Corporation, Beijing, China). All diets were produced by Research Diets (New Brunswick, NJ, USA). On day 1 after birth, the litter sizes of both groups were homogenized to six pups (3 male and 3 female mice), to ensure no nutritional bias between litters. The diets were administered throughout gestation and lactation. All offspring was weaned at 3 weeks of age. Following weaning, the offspring were divided into the following sub-groups: CC (control diet-control diet), CL (control diet-low chromium diet), LC (low chromium diet-control diet), and LL (low chromium diet-low chromium diet, *n* = 8/group, one female pup from each litter was randomly assigned to the experimental groups). The mice were maintained in a light-dark cycle (12 h light and 12 h dark) and were given free access to food and water. Unbalanced maternal nutrition differentially impacted lipid metabolism and phenotypic expression in male and female offspring \[[@B17-nutrients-08-00488],[@B18-nutrients-08-00488]\]. For this reason, the current study only focused on female offspring. The specific study design is shown in [Figure 1](#nutrients-08-00488-f001){ref-type="fig"}. At the end of the experimental period (32 weeks of age), female mice (*n* = 8/group) were sacrificed. After 10 h of fasting, the mice were anesthetized (ketamine 100 mg/kg i.p., Pharmacia and Upjohn Ltd., Crawley, UK), and blood samples were collected from the intraorbital retrobulbar plexus Adipose tissue of the offspring was quickly collected and stored at −80 °C for further analysis.

2.2. Serum Chromium Levels {#sec2dot2-nutrients-08-00488}
--------------------------

Serum chromium levels in mothers (at weaning) and in the offspring at 32 weeks were determined using an atomic absorption spectrometer (Atomic Absorption Spectrophotometer, Hitachi, Japan).

2.3. Measurement of Body Weight and Food Intake {#sec2dot3-nutrients-08-00488}
-----------------------------------------------

The body weight of the offspring was recorded at birth, 3 weeks, and 32 weeks of age. Food consumption of the offspring was recorded at 32 weeks. Food consumption was quantified by subtracting the amount of food remaining at the end of the week from the total amount of food given at the beginning of the week. The average amount of food consumed per mouse was determined by dividing the total amount consumed by the number of mice.

2.4. Measurement of Serum Leptin, Adiponectin and Inflammatory Factors {#sec2dot4-nutrients-08-00488}
----------------------------------------------------------------------

Serum concentrations of leptin, adiponectin, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), monocyte chemotactic protein 1 (MCP-1), and interleukin-1β (IL-1β) were measured using enzyme-linked immunosorbent assay (ELISA, Abcam, Cambridge, MA, USA).

2.5. Measurement of Serum Oxidative Stress and Antioxidant Markers {#sec2dot5-nutrients-08-00488}
------------------------------------------------------------------

Malondialdehyde (MDA) concentration and reduced/oxidized glutathione (GSH/GSSG) were measured using thiobarbituric acid (TBA) and Thiol Green Indicator fluorometric method (Abcam, Cambridge, MA, USA) as oxidative stress and antioxidant markers, respectively.

2.6. Measurement of Serum Total Cholesterol (TC), Triglyceride (TG), High-Density Lipoproterin Cholesterol (HDL), and Low-Density Lipoprotein Cholesterol (LDL) {#sec2dot6-nutrients-08-00488}
---------------------------------------------------------------------------------------------------------------------------------------------------------------

Serum TC, TG, HDL, and LDL concentrations were determined using an enzyme end-point method via a commercial kit (Roche Diagnostics, GmbH, Mannheim, Germany).

2.7. Measurement of Adipose Tissue Weight {#sec2dot7-nutrients-08-00488}
-----------------------------------------

At 32 weeks, mice were sacrificed and retroperitoneal, mesenteric, and ovarian fat were carefully removed and weighed. The adiposity index (AI) was computed as followings \[[@B19-nutrients-08-00488]\], $$\text{AI} = \frac{\text{sums\ of\ mass\ from\ all\ three\ fat\ sources}}{\text{total\ body\ mass}}$$

2.8. Methyl-DNA Immunoprecipitation and Microarray Hybridization {#sec2dot8-nutrients-08-00488}
----------------------------------------------------------------

Fat collected from three CC mice and LC mice was used for methyl-DNA immunoprecipitation (MeDIP) experiment. Genomic DNA (gDNA) was extracted from fat samples using a DNeasy Blood & Tissue Kit (Qiangen, Fremont, CA, USA). The purified gDNA was then quantified and quality was assessed using Nanodrop ND-1000 (NanoDrop Technologies, Wilmington, DE, USA). To perform the MeDIP experiment, first, gDNA was sonicated into random 200--1000 bp pieces. Next, 1 µg of fragmented DNA was used for immunoprecipitation with mouse monoclonal anti-5-methylcytidine (Diagenode, Liege, Belgium) at 4 °C overnight. To recover the immunoprecipitated DNA fragments, anti-mouse IgG magnetic beads (ThermoFisher Scientific, Carlsbad, CA, USA) were added and incubated for an additional 2 h at 4 °C with agitation. Then, immunoprecipitated methylated DNA and input gDNA was labeled with Cy5 and Cy3 fluorophores, respectively. Labelled DNA was hybridized to the Arraystar Mouse ReqSeq Promoter Array (Agilent, Waldbronn, Germany). This array contained all well-characterized RefSeq gene (approximately 22,327 genes) promoter regions (from −1300 bp to 500 bp transcription start sites (TSSs)). Finally, arrays were washed and scanned with an Agilent Scanner G2505C (Agilent Technologies, Waldbronn, Germany). After normalization, methylation peaks in the raw data were analyzed using SignalMap software (Roche Diagnostics, GmbH, Mannheim, Germany). We computed the modified Kolmogorov--Smirnov test on the adjacent probes using sliding windows to predict enriched regions across the array. To separate strong CpG islands from weak CpG islands, promoters were categorized into three levels: high CpG promoters/regions (HCP), intermediate CpG promoters/regions (ICP) and low CpG promoters/regions (LCP) \[[@B20-nutrients-08-00488]\].

2.9. Differential Methylated Genes Pathway Analysis {#sec2dot9-nutrients-08-00488}
---------------------------------------------------

To determine the biological meaning to the differentially methylated genes, the subset of methylated genes was analyzed by applying the Gene Ontology (GO) classification system and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways database using DAVID (Database for Annotation, Visualization and Integrated Discovery) software \[[@B21-nutrients-08-00488]\].

2.10. Bisulfite Sequencing (BSP) {#sec2dot10-nutrients-08-00488}
--------------------------------

Bisulfite modification was performed with the EZ DNA Methylation Kit (Zymo Research, Hiss Diagnostics, Germany). The converted DNA was then amplified by PCR with primers detailed in [Table 1](#nutrients-08-00488-t001){ref-type="table"}. Primers were designed using Methyl Primer Express Software version 1.0 (Applied Biosystems, Foster City, CA, USA). PCR products were purified using agarose gels (Invitrogen, Carlsbad, CA, USA) and ligated to the pMD18-T Vector (Takara, Shiga, Japan). The plasmids were then purified using the PureLink Miniprep kit (Invitrogen, Thermo Scientific Inc., Waltham, MA, USA). Positive clones were confirmed by PCR, and a minimum of 10 clones from each mouse (*n* = 8 mice/group) were sequenced using ABI PRISM 7700 Sequence Detection (Applied Biosystems, Foster City, CA, USA). Sequence analysis was performed using QUMA \[[@B22-nutrients-08-00488]\].

2.11. Quantitative Real Time RT-PCR {#sec2dot11-nutrients-08-00488}
-----------------------------------

The data (*n* = 8/group) were further analyzed for the expression of BSP-validated genes and downstream genes. The total RNA was prepared from fat stored at −80 °C using the Qiagen RNeasy Mini Kit (Qiagen, Germantown, MD, USA). cDNA was synthesized from the reverse transcription of the total RNA using an oligodesoxythymidine primer and the TakaRa RT kit (Takara, Shiga, Japan). The experimental real-time PCR signals were normalized to that of *Gadph* gene. Real-time amplification was performed using the ABI 7900 thermocycler (Applied Biosystems, Foster City, CA, USA). The fold change was calculated using the comparative Ct method. The primer sequences for quantitative real-time PCR are shown in [Table 2](#nutrients-08-00488-t002){ref-type="table"}.

2.12. Statistical Analysis {#sec2dot12-nutrients-08-00488}
--------------------------

Results are shown as means ± SD; *n* represents the number of mice analyzed. Unpaired Student's *t* test was used to compare the two groups, and one-way *ANOVA* followed by Tukey's post hoc test was used when more than two groups were analyzed. For GO and KEGG pathway analysis, Fisher's exact test was used. A *p* value \< 0.05 was considered significant. Prism version 5.0 (GraphPad Software Inc., San Diego, CA, USA) was used for statistical analysis.

3. Results {#sec3-nutrients-08-00488}
==========

3.1. Maternal Body Weight and Serum Chromium Differences {#sec3dot1-nutrients-08-00488}
--------------------------------------------------------

By the end of lactation, there was no significant difference in maternal body weight between the C dams and L dams ([Table 3](#nutrients-08-00488-t003){ref-type="table"}). As expected, the serum chromium levels were significantly decreased in the L group when compared to the C group (*p* \< 0.01, [Table 3](#nutrients-08-00488-t003){ref-type="table"}).

3.2. Effects in Offspring {#sec3dot2-nutrients-08-00488}
-------------------------

### 3.2.1. Effects of Maternal Low Chromium Diet on Serum Chromium Level, Body Weight, Food Intake, and Fat Pad Weight in Offspring {#sec3dot2dot1-nutrients-08-00488}

At week 32, serum chromium levels were lower in the LL and CL groups when compared to the CC group (*p* \< 0.01, [Figure 2](#nutrients-08-00488-f002){ref-type="fig"}a). Serum chromium levels in the LC group returned to normal ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}a). The birth weight of L group and C group offspring were comparable ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}b). At weaning, there was still no significant difference in body weight between L and C group ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}c). Although food intake was comparable between the groups ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}e), body weight in the LL group and the CL group were higher than those in CC group at 32 weeks of age (*p* \< 0.05, [Figure 2](#nutrients-08-00488-f002){ref-type="fig"}d). The body weights of the LC group were higher than those of CC group (*p* \< 0.05, [Figure 3](#nutrients-08-00488-f003){ref-type="fig"}d). At 32 weeks of age, body fat pad weights were significantly higher in the LL and CL group offspring when compared to those of the offspring from the CC group (*p* \< 0.01, [Figure 2](#nutrients-08-00488-f002){ref-type="fig"}f). Rehabilitation of low chromium diet dams (LC group) did not correct fat pad weight (*p* \< 0.01, [Figure 2](#nutrients-08-00488-f002){ref-type="fig"}f).

### 3.2.2. Effects of Maternal Low Chromium Diet on Serum Lipid Profile in Offspring {#sec3dot2dot2-nutrients-08-00488}

Serum TG levels were significantly higher in the LL and LC groups' offspring when compared to those of the CC group ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}h, *p* \< 0.05). LDL in the LL group was higher than the CC group (*p* \< 0.05, [Figure 2](#nutrients-08-00488-f002){ref-type="fig"}j). However, LDL levels were corrected in the LC group. At 32 weeks of age, serum TC and HDL were not significantly different among the offspring across all groups ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}g,i).

### 3.2.3. Effects of Maternal Low Chromium Diet on Serum Adiponectin, Leptin, and Pre-Inflammation Cytokines in Offspring {#sec3dot2dot3-nutrients-08-00488}

There was no significant differences among the groups in serum adiponectin, leptin, IL-6, and IL-1β values at 32 weeks of age ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}k,l,n,o). Only serum TNF-α levels were significantly higher in the LL, LC, and CL groups when compared to that of the CC group ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}m, *p* \< 0.05).

### 3.2.4. Effects of Maternal Low Chromium Diet on Serum Oxidative Stress and Antioxidant Markers in Offspring {#sec3dot2dot4-nutrients-08-00488}

Serum MDA levels were significantly higher in the LC and LL group when compared to that of the CC group at 32 weeks of age ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}p, *p* \< 0.01 and *p* \< 0.05, respectively). There was no significant difference among the groups in serum GSH ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}q). Serum GSSG levels were significantly higher in LC, CL, and LL groups than that in CC group ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}r, *p* \< 0.01). Thus, serum GSH/GSSG ratio was significant lower in LC, CL, and LL groups than CC group ([Figure 2](#nutrients-08-00488-f002){ref-type="fig"}s, *p* \< 0.01).

### 3.2.5. Effects of Maternal Low Chromium Diet on Genome-Wide DNA Methylation in Adipose Tissue Collected from Offspring {#sec3dot2dot5-nutrients-08-00488}

First, we obtained a CpG promoter methylation profile of the LC group and compared it to that of the CC group (GEO database: GSE82030). This comparison showed that 4.8% (1214 *loci*) of promoters in 1145 genes were hypomethylated in the LC group, particularly on chromosomes 2, 4, 5, 7, 9, 11, and 17, which have more promoters with differential methylation (Peak Score \> 2). In contrast, fewer promoters showed a trend toward hypermethylation in the LC group, just 1.8% (411 *loci*) of promoters ([Figure 3](#nutrients-08-00488-f003){ref-type="fig"}a). Among the hypomethylated promoters, 963 (79.3%) were located in HCP, 188 (15.5%) in ICP, and 63 (5.2%) in LCP. And among hypermethylated promoters, 73 (17.8%) were located in HCP, 90 (21.9%) in ICP, and 248 (60.3%) in LCP ([Figure 3](#nutrients-08-00488-f003){ref-type="fig"}b).

### 3.2.6. Functional Analysis Using DAVID {#sec3dot2dot6-nutrients-08-00488}

Next, functional analysis of hypomethylated genes was performed. Function analysis revealed that hypomethylated genes were involved in the regulation of transcript, transcription, chromatin organization, and so on ([Table 4](#nutrients-08-00488-t004){ref-type="table"}, [Figure 4](#nutrients-08-00488-f004){ref-type="fig"}). Biological pathway impacted by hypomethylated genes include gap junction and the mitogen-activated protein kinase (MAPK) signaling pathway ([Table 5](#nutrients-08-00488-t005){ref-type="table"}). [Figure 5](#nutrients-08-00488-f005){ref-type="fig"} and [Table 6](#nutrients-08-00488-t006){ref-type="table"} illustrate that the MAPK signaling pathway in the LC group affected genes exhibiting promoter hypomethylation in the LC group; this was in contrast to what was observed in the CC group.

### 3.2.7. Bisulfite Sequencing (BSP) {#sec3dot2dot7-nutrients-08-00488}

Bisulfite Sequencing (BSP) on four hypomethylated promoters was performed. Five to 35 CpGs for each gene were involved in the analysis. The methylation percentages of these promoters are shown in [Figure 6](#nutrients-08-00488-f006){ref-type="fig"}a--e. Mitogen-activated protein kinase kinase kinase 4 (*Map3k4*), mitogen-activated protein kinase kinase kinase 5 (*Map3k5*), mitogen-activated protein kinase 14 (*Mapk14*), and TGF-β-activated kinase 1/MAP3K7 binding protein 2 (*Tab2*) were significantly hypomethylated in the LC group, compared to the CC group (*p* \< 0.05). This result confirmed the results acquired using the DNA methylation array.

### 3.2.8. Real-Time RT PCR Assay for BSP-Validated Hypomethylated Genes and Downstream Genes {#sec3dot2dot8-nutrients-08-00488}

To explore whether hypomethylated promoters can affect gene expression, the expression of four genes (*Map3k4*, *Map3k5*, *Mapk14*, and *Tab2*) regulated by these hypomethylated promoters and two downstream genes (*Atf2*, *Pparg*) was analyzed by real-time PCR. The results showed that the LC group had significantly high expression levels of *Map3k4*, *Map3k5*, *Mapk14*, *Tab2*, *Atf2*, and *Pparg* compared to CC group (*p* \< 0.01, [Figure 6](#nutrients-08-00488-f006){ref-type="fig"}f).

4. Discussion {#sec4-nutrients-08-00488}
=============

Most importantly, in this study we found that body weight was comparable among the different groups at birth and at 3 weeks of age. However, at 32 weeks, pups from low chromium diet dams were heavier than those of the control group. Switching to the control diet did not correct the body weight increase. Other studies have reported that maternal chromium restriction significantly increased body weight from 12 months of age. Rehabilitation regimes did not correct the change \[[@B16-nutrients-08-00488]\]. It has also been reported that dietary vitamin B~12~ restriction increased body weight from weaning \[[@B23-nutrients-08-00488]\].

In our study, food intake was comparable among all groups at 32 weeks. However, maternal chromium restriction increased fat pad weight in offspring at 32 weeks of age. Reversing the diet did not correct this change. Venu et al. found that offspring from vitamin-restricted dams had a significantly higher percentage of body adipose from day 100 \[[@B24-nutrients-08-00488]\].

In addition, maternal chromium restriction may increase serum TG and LDL in offspring at 32 weeks of age; reversing the diet corrected LDL levels only. Other groups have found that maternal vitamin or chromium restriction may also significantly increase circulating triglyceride levels \[[@B16-nutrients-08-00488],[@B24-nutrients-08-00488]\].

Moreover, maternal chromium restriction may increase serum TNF-α levels. TNF-α modulates lipid metabolism and is associated with obesity. The long-term effect of maternal magnesium restriction increases plasma TNF-α in offspring at 18 months \[[@B25-nutrients-08-00488]\]. Several groups found that maternal protein restriction upregulated TNF-α expression in the liver and spleen, and increased serum TNF-α from fetal age to adulthood \[[@B26-nutrients-08-00488],[@B27-nutrients-08-00488],[@B28-nutrients-08-00488]\].

Early nutritional exposures can affect later disease risk through the epigenomic changes (DNA methylation, histone modifications, and so on). Although these epigenomic changes do not directly affect the DNA nucleotide sequence, it can be passed on to subsequent generations \[[@B8-nutrients-08-00488]\]. DNA methylation, which usually occurs at cytosines within CpG islands, is a key regulator in gene transcription. CpG islands are usually located in or near the promoters of the genes \[[@B29-nutrients-08-00488],[@B30-nutrients-08-00488]\]. The DNA methylation changes in promoter regions are negatively related to gene expression \[[@B31-nutrients-08-00488]\].

After genome-wide screening for differentially methylated promoters, we found that MAPK signaling was located at the center of many different methylated genes ([Figure 7](#nutrients-08-00488-f007){ref-type="fig"}), such as *Map3k4*, *Mapk14*, *Map3k5*, *Tab2*. MAPKs can regulate many cellular processes, such as normal cell proliferation, differentiation, and apoptosis \[[@B32-nutrients-08-00488]\]. More and more evidence shows that MAPK-dependent signal transduction is related to adipogenesis \[[@B33-nutrients-08-00488],[@B34-nutrients-08-00488]\]. The MAPK family consists of three main members: extracellular signal-regulated protein kinases (ERKs), c-Jun N-terminal kinases (JNKs), and p38 kinases. Inflammatory cytokines and many other cellular stresses may activate the p38 MAPK pathway. The p38 MAPK takes part in apoptosis and cell cycle regulation \[[@B35-nutrients-08-00488]\]. Transforming growth factor-β-activated kinase 1 (TAK1) belongs to the MAPK family \[[@B36-nutrients-08-00488]\]. TAK1 activity is regulated by TAB1, TAB2, TAB3, and TAB4 \[[@B37-nutrients-08-00488],[@B38-nutrients-08-00488]\]. The activated TAK1 induces the activation of p38 MAPK. Liu et al. found TNF-α markedly promotes the interaction between TAB2 and TAK1, leading to the phosphorylation of p38 MAPK. Pre-treatment with docosahexaenoic acid (DHA) can block the interaction between TAB2 and TAK1 and can attenuate the TNF-α-induced phosphorylation of ERK \[[@B39-nutrients-08-00488]\]. We found that maternal low chromium diet could lead to the demethylation of TAB2 and p38, and activation of *Tab2* and p38 expression. Finer et al. found that maternal gestational diabetes leads to genome-wide DNA methylation difference in the placenta and cord blood of exposed offspring. Pathways involved in MAPK signaling are enhanced in methylation genes \[[@B40-nutrients-08-00488]\]. *Nyggf4*, which is a newly discovered obesity candidate gene, may regulate the methylation levels of various isoforms of the MAPK subfamily \[[@B41-nutrients-08-00488]\].

MAPK family is sensible to imbalance of antioxidant system \[[@B42-nutrients-08-00488]\]. Our research found that maternal chromium restriction increased serum MDA level and reduced GSH/GSSG ratio in offspring. Indeed, the measurement of oxidative stress and antioxidant markers is often disturbed by interference from the assay or overestimation derived form stressing analysis conditions. However, MDA is an end-product of lipid hydroperoxide and a widely used marker of the status of oxidative stress \[[@B43-nutrients-08-00488]\]. And GSH is a critical antioxidants in vivo. It can neutralize reactive oxygen species through converting to GSSG. Reduction of the GSH/GSSH ratio is an important biomarker of oxidative stress \[[@B44-nutrients-08-00488]\]. Saben et al. identified pathways affected by oxidative stress significantly increased in placenta from obese women \[[@B45-nutrients-08-00488]\]. Maternal low protein diet increases oxidative stress and reduces anti-oxidant enzyme activity in placenta and fetal livers of rats \[[@B46-nutrients-08-00488]\]. Oxidative stress is one mechanism programming offspring metabolic outcomes.

P38 MAPK can activate PPARγ through activating transcription factor-2 (ATF-2) \[[@B47-nutrients-08-00488],[@B48-nutrients-08-00488]\]. PPARγ is a key transcription factor medicating adipocyte differentiation \[[@B49-nutrients-08-00488]\]. Our result also showed that maternal chromium restriction activate the expression of *Atp2* and *Pparg* in adipose of mice offspring. Activated *Pparg* induces the expression of lipolytic (lipoprotein lipase) and lipogenic (fatty acid synthase) enzymes, which modulate fatty acid uptake and synthesis \[[@B50-nutrients-08-00488],[@B51-nutrients-08-00488]\]. Increased PPARγ levels are observed in the adipose tissue of obese animals and humans \[[@B52-nutrients-08-00488],[@B53-nutrients-08-00488],[@B54-nutrients-08-00488]\]. Ahmad et al. found a significant upregulation of hepatic PPARγ expression in 12 months old rat pups born to vitamin B12-deficient mothers \[[@B55-nutrients-08-00488]\].

5. Conclusions {#sec5-nutrients-08-00488}
==============

In summary, this study is the first to demonstrate a linkage among maternal low chromium diet, the regulation of methylation levels in MAPK pathway genes, and dysfunctional lipid metabolism in offspring. This could lead to adipogenesis and lipogenesis and could contribute to an enhanced susceptibility to the development of obesity in later life. Identifying the biological underpinnings of these mechanisms could help us find early interventional treatments for offspring due to maternal undernutrition. Based on the results revealed by this study, the MAPK pathway genes methylation could be considered as a possible target to modulate the development of lipid dysfunction in the offspring born from mothers with chromium restriction diet during pregnancy.
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![The timeline of the animal experiments.](nutrients-08-00488-g001){#nutrients-08-00488-f001}

###### 

Effects of maternal low chromium diet on serum chromium (**a**); body weight (**d**); food intake (**e**); fat pad weight (**f**); serum total cholesterol (**g**); triglyceride (**h**); HDL (**i**) and LDL (**j**); leptin (**k**); adiponectin (**l**); TNF-α(m); IL-6 (**n**); IL-1β (**o**); MDA (**p**); GSH (**q**); GSSG (**r**); GSH/GSSG (**s**) at 32 weeks of age; birth weight (**b**) and weaning weight (**c**). Values are mean ± SD, *n* = 8 per group. \* *p* \< 0.05, \*\* *p* \< 0.01.
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![Distribution of differentially methylated promoters on chromosomes (**a**) and promoters with respect to the cytosine polyguanine (CpG) content (**b**), including high CpG promoters/regions (HCP), intermediate CpG promoters/regions (ICP), and low CpG promoters/regions (LCP)in low chromium diet-control diet (LC) group.](nutrients-08-00488-g003){#nutrients-08-00488-f003}

![Gene ontology classifications in biology process for hypomethylated genes. The gene ontology (GO) term is on the *y*-axis, number of genes is on the *x*-axis, and the *p*-value indicating significance of enrichment is on the right side.](nutrients-08-00488-g004){#nutrients-08-00488-f004}

![Promoter-specific DNA methylation of genes in the Kyoto Encyclopedia of Genes and Genomes (KEGG) mitogen-activated protein kinase (MAPK) signaling pathway. The red box indicates hypomethylated gene promoters and the map was provided by KEGG Pathway Database.](nutrients-08-00488-g005){#nutrients-08-00488-f005}

![Effects of maternal low chromium diet on methylation of *Map3k4* (**a**); *Mapk14* (**b**); *Map3k5* (**c**); and *Tab2* (**d**) and relative expression (**f**) of genes in adipose of offspring. For bisulfite sequencing (BSP) results, white circles represent unmethylated CpGs, and black circles represent methylated CpGs (**a**--**d**); figure e shows the analysis of DNA methylation status. Values are expressed as means ± SD, *n* = 8 per group. For BSP, pooled DNA of eight mice adipose for each group is what we used for analysis. For each gene in each group, 10 clones randomly selected were analyzed and represent the average methylation level for the indicated genes. \* *p* \< 0.05, \*\**p* \< 0.01, vs. CC. *Map3k4*: mitogen-activated protein kinase kinase kinase 4; *Mapk14*: mitogen-activated protein kinase 14; *Map3k5*: mitogen-activated protein kinase kinase kinase 5; *Tab2*: TGF-β-activated kinase 1/MAP3K7 binding protein 2; *Pparg*: peroxisome proliferator activated receptor gammas; *Atf2*: activating transcription factor 2.](nutrients-08-00488-g006){#nutrients-08-00488-f006}

![The possible mechanism of maternal chromium restriction on offspring. Maternal chromium restriction induces oxidative stress, then leads to hypomethylate in Map3k5 (Ask1), *Tab2*, Map3k4 (Mekk4), Mapk14 (p38 MAPK) promoter, activates Ppar-γ through Atf-2 to accelerate adipogenesis in adipose of mice offspring. The red box indicates hypomethylated gene promoters, and upregulated gene expression. Map3k4: mitogen-activated protein kinase kinase kinase 4; *Mapk14*: mitogen-activated protein kinase 14; *Map3k5*: mitogen-activated protein kinase kinase kinase 5; *Tab2*: TGF-beta activated kinase 1/MAP3K7 binding protein 2; *Tak1*: Transforming growth factor-β-activated kinase 1; *Ask1*: apoptosis signal-regulated kinase 1; Mkk3/6: mitogen-activated protein kinase kinase 3/6; *Pparγ*: peroxisome proliferator activated receptor gammas; *Atf2*: activating transcription factor 2.](nutrients-08-00488-g007){#nutrients-08-00488-f007}

nutrients-08-00488-t001_Table 1

###### 

PCR Primers for bisulfite sequencing.

  Gene                                 Accession Number   Primer Sequences (from 5′ to 3′)   Production Size   CpG Number
  ------------------------------------ ------------------ ---------------------------------- ----------------- ------------
  *Map3k4*                             NM_011948          F: 5′-AATGATTGAAAGATGTTTTGTT-3′    303               5
  R: 5′-TTCATAAACTAAAACTCAAAATCTC-3′                                                                           
  *Mapk14*                             NM_001168513       F: 5′-GGAGTAAGTAGGGTGGTTTTGT-3′    382               30
  R: 5′-CAAACTTTACCCTACAACTCCTC-3′                                                                             
  *Map3k5*                             NM_008580          F: 5′-GTAAGGGAGTTGTTGYGGAGTA-3′    258               35
  R: 5′-AAAAAAACAAAACTTCCTCCTCTT-3′                                                                            
  *Tab2*                               NM_138667          F: 5′-TGTTGATTAAGGAAAGTTTAGYG-3′   252               34
  R: 5′-CRAAACCCTACAAACCCTAAC-3′                                                                               

PCR: Polymerase Chain Reaction; *Map3k4*: mitogen-activated protein kinase kinase kinase 4; *Mapk14*: mitogen-activated protein kinase 14; *Map3k5*: mitogen-activated protein kinase kinase kinase 5; *Tab2*: transforming growth factor-β (TGF-β)-activated kinase 1/MAP3K7 binding protein 2.

nutrients-08-00488-t002_Table 2

###### 

Primer using in real time PCR.

  Gene                              Accession Number   Primer Sequences (from 5′ to 3′)    Production Size
  --------------------------------- ------------------ ----------------------------------- -----------------
  *Map3k4*                          NM_011948          F: 5′-ATTGGAGAAGGACAGTAT-3′         107
  R: 5′-ATAGTCTTGTGGTCGTTA-3′                                                              
  *Mapk14*                          NM_001168513       F: 5′-TGTTCTGTCTATCTCACTTC-3′       75
  R: 5′-GAGGCACTTGAATGGTAT-3′                                                              
  *Map3k5*                          NM_008580          F: 5′-AATAATGAAGTTGAGGAGAAGACA-3′   78
  R: 5′-AGAGGAAGCACCGAAGTT-3′                                                              
  *Tab2*                            NM_138667          F: 5′-TATCAGTGCTTGGAATGG-3′         143
  R: 5′-GACCTTCTTAACGCTCAT-3′                                                              
  *Pparg*                           NM_001127330       F: 5′-GCATCAGGCTTCCACTAT-3′         75
  R: 5′-CTTCAATCGGATGGTTCTTC-3′                                                            
  *Atf2*                            NM_001025093       F: 5′-GGCGTTCAAGCAGGATTC-3′         106
  R: 5′-TGACACTGAGACCATAGCAATA-3′                                                          

*Map3k4*: mitogen-activated protein kinase kinase kinase 4; *Mapk14*: mitogen-activated protein kinase 14; *Map3k5*: mitogen-activated protein kinase kinase kinase 5; *Tab2*: TGF-β-activated kinase 1/MAP3K7 binding protein 2; *Pparg*: peroxisome proliferator activated receptor gammas; *Atf2*: activating transcription factor 2.

nutrients-08-00488-t003_Table 3

###### 

Body weight, fasting blood glucose and serum chromium level in dams at weaning.

  Groups                   C             L
  ------------------------ ------------- ------------------
  Body weight (g)          23.1 ± 3.5    22.3 ± 3.4
  Serum chromium (ng/mL)   0.89 ± 0.22   0.45 ± 0.09 \*\*

C, control diet group; L, low chromium diet group. Values are mean ± SD, *n* = 8 per group. \*\* *p* \< 0.01 vs. C.

nutrients-08-00488-t004_Table 4

###### 

Annotation of LC group hypomethylated promoter genes (*p* value \< 0.00001).

  Term                                                          Term Number   Count   *p*-Value                 Fold Enrichment
  ------------------------------------------------------------- ------------- ------- ------------------------- -----------------
  Biological process                                            \-            \-      \-                        \-
  regulation of transcription                                   GO:0045449    189     $1.83 \times 10^{- 9}$    1.5015
  transcription                                                 GO:0006350    158     $2.21 \times 10^{- 9}$    1.5775
  chromatin organization                                        GO:0006325    43      $1.75 \times 10^{- 7}$    2.4151
  chromatin modification                                        GO:0016568    33      $3.57 \times 10^{- 6}$    2.4737
  chromosome organization                                       GO:0051276    46      $9.60 \times 10^{- 6}$    2.0145
  regulation of transcription from RNA polymerase II promoter   GO:0006357    62      $1.19 \times 10^{- 5}$    1.7807
  regulation of transcription, DNA-dependent                    GO:0006355    118     $5.50 \times 10^{- 5}$    1.4250
  negative regulation of transcription, DNA-dependent           GO:0045892    36      $6.18 \times 10^{- 5}$    2.0679
  negative regulation of gene expression                        GO:0010629    44      $6.38 \times 10^{- 5}$    1.8987
  negative regulation of transcription                          GO:0016481    41      $6.63 \times 10^{- 5}$    1.9500
  regulation of RNA metabolic process                           GO:0051252    119     $6.89 \times 10^{- 5}$    1.4149
  negative regulation of RNA metabolic process                  GO:0051253    36      $7.05 \times 10^{- 5}$    2.0546
  glycoprotein biosynthetic process                             GO:0009101    19      $9.41 \times 10^{- 5}$    2.8731
  Cellular componts                                             \-            \-      \-                        \-
  nuclear lumen                                                 GO:0031981    86      $2.10 \times 10^{- 8}$    1.8592
  intracellular organelle lumen                                 GO:0070013    101     $8.79 \times 10^{- 8}$    1.7017
  organelle lumen                                               GO:0043233    101     $1.00 \times 10^{- 7}$    1.6972
  endomembrane system                                           GO:0012505    58      $2.07 \times 10^{- 7}$    2.0695
  membrane-enclosed lumen                                       GO:0031974    102     $2.64 \times 10^{- 7}$    1.6585
  Golgi apparatus                                               GO:0005794    68      $3.70 \times 10^{- 7}$    1.9034
  nucleoplasm                                                   GO:0005654    57      $1.54 \times 10^{- 5}$    1.8165
  Golgi apparatus part                                          GO:0044431    29      $2.07 \times 10^{- 5}$    2.4388
  Golgi membrane                                                GO:0000139    20      $9.16 \times 10^{- 5}$    2.7868
  Molecular Function                                            \-            \-      \-                        \-
  DNA binding                                                   GO:0003677    167     $1.62 \times 10^{- 12}$   1.6952
  transcription regulator activity                              GO:0030528    113     $1.85 \times 10^{- 8}$    1.6939
  transcription factor activity                                 GO:0003700    76      $1.22 \times 10^{- 6}$    1.7706
  metal ion binding                                             GO:0046872    260     $8.05 \times 10^{- 5}$    1.2209
  cation binding                                                GO:0043169    262     $8.06 \times 10^{- 5}$    1.2192

nutrients-08-00488-t005_Table 5

###### 

KEGG pathway in LC group hypomethylated genes (*p* \< 0.01).

  Pathway Name             Pathway Term   Gene Count   Fold Enrichment   *p*-Value
  ------------------------ -------------- ------------ ----------------- -----------
  Gap junction             mmu04540       11           2.6025            0.008845
  MAPK signaling pathway   mmu04010       23           1.7660            0.009097

nutrients-08-00488-t006_Table 6

###### 

LC group hypomethylation genes in MAPK signaling pathway (peak score \> 2).

  Gene Name       Accession      Chromosome   Peak to TSS   Promoter Classification   Peak Score   Peak M Value
  --------------- -------------- ------------ ------------- ------------------------- ------------ --------------
  Rac1            NM_009007      chr5         264           HCP                       2.42         0.550
  Rela            NM_009045      chr19        349           HCP                       2.65         0.477
  Prkcb           NM_008855      chr7         350           HCP                       2.96         0.370
  Cacna1h         NM_001163691   chr17        37            HCP                       3.1          0.338
  Map3k4          NM_011948      chr17        −422          HCP                       3.48         0.334
  *Tab2*          NM_138667      chr10        −175          HCP                       3.68         0.312
  Fgf3            NM_008007      chr7         336           HCP                       2.08         0.305
  Braf            NM_139294      chr6         105           HCP                       2.48         0.265
  Mapk14          NM_001168513   chr17        −833          HCP                       3.38         0.259
  Mapk14          NM_001168514   chr17        393           HCP                       3.38         0.259
  Fgf18           NM_008005      chr11        85            HCP                       2.93         0.258
  Map3k5          NM_008580      chr10        −291          HCP                       2.6          0.254
  Cacna2d3        NM_009785      chr14        −314          HCP                       2.94         0.251
  Pdgfa           NM_008808      chr5         −301          HCP                       3.42         0.247
  Fgf8            NM_010205      chr19        −231          HCP                       2.59         0.218
  Cacnb4          NM_001037099   chr2         145           ICP                       2.27         0.169
  Fgf11           NM_010198      chr11        117           ICP                       2.11         0.144
  Hras1           NM_001130444   chr7         −254          HCP                       2.36         0.121
  Sos1            NM_009231      chr17        −350          HCP                       2.49         0.109
  Cacna1g         NM_001177890   chr11        −401          HCP                       2.15         0.060
  1500003O03Rik   NM_019769      chr2         437           HCP                       2.37         0.053
  Dusp16          NM_130447      chr6         −410          HCP                       2.18         0.038
  Prkx            NM_016979      chrX         −253          HCP                       2.22         0.035
  Nfkb2           NM_001177370   chr19        −536          ICP                       2.1          0.012

TSS, transcription start sites; Peak to TSS, the distance from the center of the peak to the TSS. ("-": peak center in upstream of the TSS); Peak Score, the average of −log~10~*^p^*^−value^ from the probes within the peak. The score reflects the probability of positive enrichment. (cut-off = 2); Peak M Value, the median of log~2~^−ratio^ from the probes within the peak. The score reflects the methylation degree; HCP, high CpG promoters/regions; ICP, intermediate CpG promoters/regions; LCP, low CpG promoters/regions.
